Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20969167 | 1.00 | TSHR (0.33) | TSHRALOX15 | |
| SCHEMBL18107140 | 1.00 | TSHR (0.33) | TSHRALOX15 | |
| SCHEMBL18107138 | 1.00 | TSHR (0.33) | TSHRALOX15 | |
| SCHEMBL28429272 | 0.76 | TRPA1 (0.32) | TSHR | |
| SCHEMBL27831777 | 0.76 | TSHR (0.46) | TSHR | |
| SCHEMBL25355196 | 0.71 | — | — | |
| Acetic Acid Methyl Ester SCHEMBL10879196 | 0.68 | ALDH1A1 (0.39) | ALOX15 | |
| SCHEMBL17106177 | 0.68 | ALOX15 (0.41) | ALOX15 | |
| SCHEMBL23682623 | 0.68 | TSHR (0.34) | TSHRALOX15 | |
| SCHEMBL20969166 | 0.67 | TSHR (0.33) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3521409-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2024-08-14 | — | — | EP | disclosed |
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | disclosed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | TSHR 4787/4885ALOX15 599/4885 |
| US-20150275132-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | TSHR 4787/4885ALOX15 599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.